Title: Unique Clinical Characteristics of Primary Hyperparathyroidism and Role of Nuclear Medicine Imaging

Authors: Amit Sharma, Anurag Jain, Sumit Agarwal, IP Dubey, Rajeev Kumar , Braj Kishore, MS Chauhan, AG Pandit, Arun Ravi John, MG Vishnoi, Dharmesh Paliwal

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i2.134

Abstract

Primary hyperparathyroidism (PHPT) has a variable clinical expression. Symptomatic PHPT is still the predominant form of the disease in many parts of the world, especially developing countries. Because the clinical profile of the disease has changed from that described in the past, we sought to improve our understanding of the disease in patients with unusual presentations and role of nuclear medicine imaging.

Materials and Methods- We summarized the clinical presentation, biochemical, Nuclear medicine imaging and radiological features from the case records in the last six months of 7 patients at the apex hospital of Armed Forces (AHRR) who had documented as PHPT.

Results: N=7 (M2, F5), Mean age: 61.2 ± 14.6 years (38-76). Various clinical presentations as: Bony swelling, features of hypecalcaemia, recurrent kidney stones, recurrent fractures, osteoporosis, incidentaloma in USG neck.

Torsades – de – pointes, multiglandular disease, Isolated Osteitis Fibrosa Cystica left maxilla and concurrent Paget’s disease were unusual clinical characteristics.

99mTc MIBI scan was able to localize parathyroid adenoma in 5 out of 7 patients. Both USG and MIBI scan was not able to localize the lesion in one patient. In one patient MIBI scan does not localize the adenoma, however ultrasound (USG) reveals three hypoechoic lesions. 99mTc Methylene Diphosphonate (MDP) scan was done in 2 patients. Isolated bone lesion was detected in one patient and metabolic super scan was detected in another.

Conclusion: PHPT can have varied presentations. It continues to be a symptomatic disorder with skeletal and renal manifestation at younger age groups in India. MIBI parathyroid imaging is the most sensitive imaging modality in preoperative management. Additional single-photon emission computed tomography to planar scintigraphy provides information for localizing parathyroid lesions, to differentiate thyroid from parathyroid lesions. MIBI imaging is having limited role in multiglandular disease.

References

1.      Albright F, Aub JC, Bauer W. Hyperpara-thyroidism: volume 2, a common clinical and polymorphic condition as illustrated by 17 proven cases from one clinic. J Am Med Assoc. 1934; 102: 1276-1287.

2.      Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O’Fallon WM, Melton LJ 3rd. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med.1997; 126: 433-440.

3.      Mundy GR, Cove DH, Fisken R. Primary hyper-parathyroidism: changes in the pattern of clinical presentation. Lancet. 1980; 1: 1317-1320.

4.      Rao DS. Primary hyperparathyroidism: changing patterns in presentation and treatment decisions in the eighties. Henry Ford Hospital. Med J. 1985; 33: 194-197.

5.      Silverberg SJ, Sahne E, Demster DW, Bilezikian JP. The effect of Vitamin D insufficiency in patients with primary hyperparathyroidism. AM J MED1999; 107: 561-567.

6.      S. K. Mishra, G. Agarwal, D. K. Kar, S. K. Gupta, A. Mithal, and J. Rastad, “Unique clinical characteristics of primary hyperp-arathyroidism in India,” British Journal of Surgery,vol. 88, no. 5, pp. 708–714, 2001.

7.      P. V. Pradeep, A. Mishra, G. Agarwal, A. Agarwal, A. K. Verma, and S. K. Mishra, “Long-term outcome after parathyroid-dectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency,” World Journal of Surgery, vol. 32, no. 5, pp. 829–835, 2008.

8.      S. S. Shrikande and G. V. Talvalkar, “Parathyroid tumours: a study of 10 cases,” Indian Journal of Cancer, vol.17,no.3,pp.164–168, 1980.

9.      L. A. Mack and J. L. Pasieka, “Asympt-omatic primary hyperparathyroidism: a surgical perspective,” Surgical Clinics of North America, vol. 84, no. 3, pp. 803–816, 2004.

10.  J. P. Bilezikian and S. J. Silverberg, “Asymptomatic primary hyperparathy-roidism,” The New England Journal of Medicine, vol. 350, no. 17, pp. 1746–1751, 2004.

11.  A. Khan, A. Grey, and D. Shoback, “Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 373–381, 2009.

12.   A. Bhansali, S. R. Masoodi, S. Reddy et al., “Primary hyperparathyroidism in north India: a description of 52 cases,”Annals of Saudi Medicine, vol. 25, no. 1, pp. 29–35, 2005.

13.  G.Priya,V.P.Jyotsna,N.Guptaetal.,“Clinical and laboratory profile of primary hyperparathyroidism in India,” Postgraduate Medical Journal, vol. 84, no. 987, pp. 34–39, 2008.

14.  R. A. Gopal, S. V. Acharya, T. R. Bandgar et al., “Clinical profile of primary hyperparathyroidism from western India: a single center experience,” Journal of Postgraduate Medicine,vol.56, no. 2, pp. 79–84, 2010.

15.  A. Bhansali, S. R. Masoodi, S. Bhadada, B. R. Mittal, A. Behra, and P. Singh, “Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: compare-ison with radionuclide scintigraphy and surgery,” Clinical Endocrinology, vol. 65, no. 3, pp. 340–345, 2006.

16.  A. Agarwal, R. K. George, S. K. Gupta, and S. K. Mishra, “Pancreatitis in patients with primary hyperparathyroidism,” Indian Journal of Gastroenterology, vol. 22, no. 6, pp. 224–225,2003.

17.  M. M. Kapur, M. S. Agarwal, A. Gupta, M. C. Misra, and M. M. Ahuja, “Clinical biochemical features of primary hyperparathyroidism,” The Indian Journal of Medical Research, vol. 81, pp. 607–612, 1985.

18.  N.A. Younes,I.S. Al-Trawneh, N.M. Albesoul, B.R. Hamdan, and A. S. Sroujieh, “Clinical spectrum of prim-ary hyperparathyroidism,” Saudi Medical Journal, vol. 24, no. 2, pp. 179–183, 2003.

19.  K. Uhluhizarci, R. Colak, M. Kula et al., “Evaluation of sixteen patients with hyperparathyroidism,” Turkish Journal of Endocrinology and Metabolism, vol. 4, no. 4, pp. 139–142, 2000.

20.  F.K.W.Chan,S.C.Tiu,K.L.Choietal.,“Primary hyperparathyroidism in Hong Kong: an analysis of 44 cases,”Hongkong Medical Journal, vol. 4, pp. 229–234, 1998.

21.  P. V. Pradeep et al, Systematic Review of Primary Hyperparathyroidism in India: The Past, Present, and the Future Trends International Journal of Endocrinology Volume 2011, Article ID 921814, 7 pages

Corresponding Author

Amit Sharma

MBBS, DRM in Nuclear Medicine, MO Nuclear Medicine,

Army Hospital R and R, Delhi 110010

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.